Human Exposomic Determinants of Immune Mediated Diseases
akronüüm:
HEDIMED
algus:
2020-01-01
lõpp:
2024-12-31
programm:
H2020 - Horisont 2020
alaprogramm:
HEALTH - Tervishoid, demograafilised muutused ja heaolu
instrument:
RIA
projektikonkurss:
H2020-SC1-2019-Single-Stage-RTD
projekti number:
874864
kestus kuudes:
60
partnerite arv:
22
lühikokkuvõte:
Immune-mediated diseases (IMDs) are increasing rapidly in the developed countries constituting a huge medical, economic and societal challenge. The reasons to this epidemic are not known, but exposome needs to play an important role since genetic factors
